Thyroid Monitoring After Intravascular Iodinated Contrast Media in Infants and Children Through 3 Years of Age

In March 2022, the US Food and Drug Administration issued a drug safety communication (DSC) recommending monitoring of thyroid function in children up to 3 years of age who receive intravascular injection of iodinated contrast media (IV ICM) for medical imaging. In response, a group of pediatric and imaging experts convened to review the current scientific evidence on thyroid dysfunction after IV ICM and to provide recommendations on thyroid testing and management after IV ICM administration in infants and children. There are considerable gaps in knowledge related to the risk of thyroid dysfunction in young children exposed to IV ICM, and we strongly recommend that high-quality prospective studies be proposed and funded to clarify the incidence, risk modifiers, natural history, and outcomes of thyroid dysfunction after IV ICM exposure in this population.

Authors

Institutions

Publication Details

Journal
PEDIATRICS
Published
2026-04-27
DOI
https://doi.org/10.1542/peds.2026-076640
Primary Topic
Acute Kidney Injury Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Thyroid Monitoring After Intravascular Iodinated Contrast Media in Infants and Children Through 3 Years of Age

Ari J. Wassner, Matthew A. Crystal, Arash Salavitabar, Audrey C. Marshall et al.
PEDIATRICS
Acute Kidney Injury Research
article

Thyroid Monitoring After Intravascular Iodinated Contrast Media in Infants and Children Through 3 Years of Age

Ari J. Wassner, Matthew A. Crystal, Arash Salavitabar, Audrey C. Marshall, Amit Lahoti, Liuska Pesce, Lucy D. Mastrandrea, Jonathan D. Wasserman, Andrew J. Bauer, Brent M. Gordon, Robert Rapaport, Bridget Hughes, Jonathan R. Dillman, Monica Forbes-Amrein, Kathleen Bethin, Ryan S. Miller, Catherine A. Dinauer
article en

Abstract

In March 2022, the US Food and Drug Administration issued a drug safety communication (DSC) recommending monitoring of thyroid function in children up to 3 years of age who receive intravascular injection of iodinated contrast media (IV ICM) for medical imaging. In response, a group of pediatric and imaging experts convened to review the current scientific evidence on thyroid dysfunction after IV ICM and to provide recommendations on thyroid testing and management after IV ICM administration in infants and children. There are considerable gaps in knowledge related to the risk of thyroid dysfunction in young children exposed to IV ICM, and we strongly recommend that high-quality prospective studies be proposed and funded to clarify the incidence, risk modifiers, natural history, and outcomes of thyroid dysfunction after IV ICM exposure in this population.

PEDIATRICSVol. 157(5)
University of Iowa (US), Cincinnati Children's Hospital Medical Center (US), Boston Medical Center (US), Nationwide Children's Hospital (US), New Haven Public Schools (US), Sinai Hospital (US), Hospital for Sick Children (CA), Rady Children's Hospital-San Diego (US), Presbyterian Hospital (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), University at Buffalo, State University of New York (US), University of Pennsylvania (US), Icahn School of Medicine at Mount Sinai (US)
Good health and well-being
Openalex Percentile: Top 15%
Acute Kidney Injury Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.